Analyst Upgrades – Allergan (NYSE:AGN) Stock Gets Upgraded By Barclays from Equal Weight to Overweight

ME Staff
-
0

Analyst Ratings For Allergan (NYSE:AGN)

Today, Allergan (NYSE:AGN) stock received an upgrade by Barclays from Equal Weight to Overweight.

Some recent analyst ratings include

  • 1/29/2018-Barclays Upgrade from a “Equal Weight ” rating to a ” Overweight” rating.
  • 1/24/2018-Morgan Stanley Reiterated Rating of Buy.
  • 1/9/2018-Deutsche Bank Reiterated Rating of Buy.

Dividend information for Allergan (NYSE:AGN)

Allergan (NYSE:AGN) pays an annual dividend of $2.80 with a yield of 1.48% and an average dividend growth of 141.00% based on a 3 Year Average..

Dividend History for Allergan (NYSE:AGN)

  • On 10/27/2017 Allergan announced a quarterly dividend of $0.70 1.58% with an ex dividend date of 11/16/2017 which will be payable on 12/15/2017.
  • On 8/2/2017 Allergan announced a Quarterly dividend of $0.70 1.12% with an ex dividend date of 8/16/2017 which will be payable on 9/15/2017.
  • On 5/5/2017 Allergan announced a quarterly dividend of $0.70 0.01% with an ex dividend date of 5/16/2017 which will be payable on 6/15/2017.
  • On 11/2/2016 Allergan announced a quarterly dividend of $0.70 with an ex dividend date of 2/24/2017 which will be payable on 3/28/2017.
  • On 2/4/2015 Allergan announced a quarterly dividend of $0.05 0.09% with an ex dividend date of 2/5/2015 which will be payable on 3/20/2015.
  • On 10/27/2014 Allergan announced a quarterly dividend of $0.05 with an ex dividend date of which will be payable on 12/11/2014.
  • On 7/28/2014 Allergan announced a quarterly dividend of $0.05 0.12% with an ex dividend date of 8/13/2014 which will be payable on 9/5/2014.

Recent Insider Trading Activity For Allergan (NYSE:AGN)
Allergan (NYSE:AGN) has insider ownership of 0.36% and institutional ownership of 81.21%.

  • On 12/7/2017 Chris W. Bodine, Director, bought 3,030 with an average share price of $164.77 per share and the total transaction amounting to $499,253.10.
  • On 12/6/2017 Brent L. Saunders, Chairman, bought 4,600 with an average share price of $164.74 per share and the total transaction amounting to $757,804.00.
  • On 12/5/2017 Christopher J. Coughlin, Director, bought 10,000 with an average share price of $163.30 per share and the total transaction amounting to $1,633,000.00.
  • On 12/1/2017 William Meury, Insider, sold 11,807 with an average share price of $173.89 per share and the total transaction amounting to $2,053,119.23.
  • On 5/18/2017 Nesli Basgoz, Director, sold 1,889 with an average share price of $220.45 per share and the total transaction amounting to $416,430.05.
  • On 3/2/2017 Paul Bisaro, Director, sold 70,000 with an average share price of $246.68 per share and the total transaction amounting to $17,267,600.00.
  • On 12/8/2016 Nesli Basgoz, Director, sold 500 with an average share price of $188.72 per share and the total transaction amounting to $94,360.00.

Recent Trading Activity for Allergan (NYSE:AGN)
Shares of Allergan closed the previous trading session at 187.69 up +0.71 0.38% with shares trading hands.